The Massachusetts Life Sciences Center handed out $25 million in tax breaks to local companies, with 6 medical device makers taking $7.8 million of the total pot.
Funding Roundup
Titan Medical raises $12.8M for its surgical robotics
VC firm NaviMed raises $40.7M
Healthcare private capital firm NaviMed Partners raised $40.7 million in a recent fundraising round, according to regulatory filings.
The Washington D.C.-based company noted 5 unnamed participants in the round, raised through a pooled investment of fund interests.
Cayenne Medical nears $6M funding goal
Cayenne Medical is $1 million away from reaching its $6 million fundraising goal, according to a regulatory filing.
Scottsdale, Ariz.-based Cayenne Medical makes medical devices used in knee and shoulder reconstruction surgeries.
Nine unnamed investors ponied up a collective $5 million in the equity and options sale, according to the filing.
Biolase closes $5M private placement with Oracle
Biolase (NSDQ:BIOL) said it closed a $5 million private placement with Oracle Investment Management.
The surgical laser maker sold off a little more than 1.9 million shares for $2.57 each, with the deal closing on Feb. 10. The money is expected to go toward paying down its $4.6 million credit facility with Comerica Bank, according to chairman & CEO Federico Pignatelli .
Pulse Therapeutics brings in $1M for stroke treatment
Pulse Therapeutics is nearing its $1.5 million goal in an active fundraising effort that has so far brought in just over $1 million, according to a SEC filing.
St. Louis-based Pulse Therapeutics is developing stroke treatment technologies based on tiny, biologically safe iron particles that could deliver drug therapy.
Alimera raises $37.5M in private placement
Alimera Sciences (NSDQ:ALIM) raised $37.5 million in a recent funding round, planning on using the funds to support general corporate operations.
TAVI: Direct Flow lands $50M through debt financing
California-based medtech company Direct Flow Medical landed $50 million in debt financing, planning on using the new funds to support commercialization of a new transcatheter aortic valve implantation system.
Miramar Labs pulls in $10M Series D round
Miramar Labs said it landed a $10 million Series D round it plans to use to boost sales of its miraDry system.
Sunnyvale, Calif.-based Miramar makes dermatology devices including its flagship miraDry system, a laser-based treatment for excessive underarm sweat. The device, which uses microwave energy to eliminate sweat glands, recently won CE Mark approval in the European Union.
Endonovo Therapeutics lands $10M
Endonovo Therapeutics said it raised $10 million in a private placement with an unnamed investor.
The Woodland Hills, Calif.-based company is developing non-invasive, electromagnetic therapies with time-varying electromagnetic fields to regenerate tissue and organs that have been damaged by age or disease.
Lumenis sets $100M IPO terms
Lumenis Ltd. said it plans to sell 6.25 million shares at $15 to $17 apiece in its upcoming initial public offering.
That would bring in between $93.8 million and $106.3 million for the Israeli medical laser maker, which announced the IPO late last year.